vs
Side-by-side financial comparison of HWH International Inc. (HWH) and IGC Pharma, Inc. (IGC). Click either name above to swap in a different company.
HWH International Inc. is the larger business by last-quarter revenue ($206.8K vs $191.0K, roughly 1.1× IGC Pharma, Inc.). HWH International Inc. runs the higher net margin — -140.7% vs -953.4%, a 812.7% gap on every dollar of revenue. On growth, HWH International Inc. posted the faster year-over-year revenue change (-40.2% vs -53.6%). HWH International Inc. produced more free cash flow last quarter ($-217.9K vs $-2.1M).
HWH International Inc operates in the global luxury hospitality and lifestyle services industry, providing premium travel membership programs, curated high-end travel experiences, and exclusive access to luxury resorts, fine dining venues, and premium leisure facilities. Its key markets include North America, Asia Pacific, and Europe, serving high-net-worth individuals and corporate clients.
IGC Pharma, Inc. is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative cannabinoid-derived therapeutics. Its core pipeline targets treatments for neurodegenerative conditions, pain and rare diseases, with primary operations in North America and ongoing global market expansion.
HWH vs IGC — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $206.8K | $191.0K |
| Net Profit | $-291.0K | $-1.8M |
| Gross Margin | 59.8% | 51.8% |
| Operating Margin | -142.7% | -1517.8% |
| Net Margin | -140.7% | -953.4% |
| Revenue YoY | -40.2% | -53.6% |
| Net Profit YoY | 46.9% | -6.1% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $206.8K | $191.0K | ||
| Q2 25 | $310.4K | $328.0K | ||
| Q4 24 | $287.1K | $257.0K | ||
| Q3 24 | $345.5K | $412.0K | ||
| Q2 24 | $334.9K | $272.0K | ||
| Q1 24 | $286.1K | $295.0K | ||
| Q4 23 | — | $204.0K | ||
| Q3 23 | — | $291.0K |
| Q3 25 | $-291.0K | $-1.8M | ||
| Q2 25 | $83.4K | $-1.6M | ||
| Q4 24 | $-476.7K | $-1.8M | ||
| Q3 24 | $-548.5K | $-1.7M | ||
| Q2 24 | $-387.9K | $-2.4M | ||
| Q1 24 | $-1.3M | $-2.9M | ||
| Q4 23 | — | $-5.6M | ||
| Q3 23 | — | $-2.5M |
| Q3 25 | 59.8% | 51.8% | ||
| Q2 25 | 48.0% | 47.0% | ||
| Q4 24 | 39.6% | 40.5% | ||
| Q3 24 | 46.3% | 48.1% | ||
| Q2 24 | 49.2% | 59.9% | ||
| Q1 24 | 57.1% | 58.0% | ||
| Q4 23 | — | 65.2% | ||
| Q3 23 | — | 59.8% |
| Q3 25 | -142.7% | -1517.8% | ||
| Q2 25 | 24.5% | -580.8% | ||
| Q4 24 | -170.2% | -730.7% | ||
| Q3 24 | -155.5% | -427.2% | ||
| Q2 24 | -120.5% | -880.9% | ||
| Q1 24 | -467.1% | -735.6% | ||
| Q4 23 | — | -1469.6% | ||
| Q3 23 | — | -856.0% |
| Q3 25 | -140.7% | -953.4% | ||
| Q2 25 | 26.9% | -487.5% | ||
| Q4 24 | -166.1% | -711.7% | ||
| Q3 24 | -158.7% | -416.7% | ||
| Q2 24 | -115.8% | -874.3% | ||
| Q1 24 | -467.2% | -978.0% | ||
| Q4 23 | — | -2739.7% | ||
| Q3 23 | — | -842.3% |
| Q3 25 | — | $-0.02 | ||
| Q2 25 | — | $-0.02 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-0.09 | ||
| Q3 23 | — | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.9M | $1.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.8M | $8.1M |
| Total Assets | $5.2M | $9.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $2.9M | $1.1M | ||
| Q2 25 | $3.7M | $454.0K | ||
| Q4 24 | $4.4M | $470.0K | ||
| Q3 24 | $836.3K | $1.5M | ||
| Q2 24 | $958.9K | $1.8M | ||
| Q1 24 | $1.1M | $1.2M | ||
| Q4 23 | — | $1.4M | ||
| Q3 23 | — | $3.1M |
| Q3 25 | $2.8M | $8.1M | ||
| Q2 25 | $3.2M | $6.1M | ||
| Q4 24 | $2.8M | $6.3M | ||
| Q3 24 | $-374.9K | $7.4M | ||
| Q2 24 | $-3.6M | $7.9M | ||
| Q1 24 | $-3.1M | — | ||
| Q4 23 | — | $9.1M | ||
| Q3 23 | — | $14.1M |
| Q3 25 | $5.2M | $9.7M | ||
| Q2 25 | $10.6M | $7.9M | ||
| Q4 24 | $6.4M | $9.1M | ||
| Q3 24 | $2.9M | $10.4M | ||
| Q2 24 | $3.1M | $10.6M | ||
| Q1 24 | $2.6M | $9.9M | ||
| Q4 23 | — | $11.3M | ||
| Q3 23 | — | $16.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-199.9K | $-2.1M |
| Free Cash FlowOCF − Capex | $-217.9K | $-2.1M |
| FCF MarginFCF / Revenue | -105.4% | -1109.4% |
| Capex IntensityCapex / Revenue | 8.7% | 15.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-199.9K | $-2.1M | ||
| Q2 25 | $26.9K | $-1.4M | ||
| Q4 24 | $-415.2K | — | ||
| Q3 24 | $-275.0K | $-996.0K | ||
| Q2 24 | $-490.8K | $-1.8M | ||
| Q1 24 | $-638.2K | $-526.0K | ||
| Q4 23 | — | $-1.6M | ||
| Q3 23 | — | $-1.6M |
| Q3 25 | $-217.9K | $-2.1M | ||
| Q2 25 | — | $-1.4M | ||
| Q4 24 | $-415.5K | — | ||
| Q3 24 | $-277.1K | $-1.0M | ||
| Q2 24 | $-516.8K | $-1.8M | ||
| Q1 24 | $-640.3K | $-541.0K | ||
| Q4 23 | — | $-1.7M | ||
| Q3 23 | — | $-1.7M |
| Q3 25 | -105.4% | -1109.4% | ||
| Q2 25 | — | -431.4% | ||
| Q4 24 | -144.7% | — | ||
| Q3 24 | -80.2% | -248.8% | ||
| Q2 24 | -154.3% | -658.1% | ||
| Q1 24 | -223.8% | -183.4% | ||
| Q4 23 | — | -811.3% | ||
| Q3 23 | — | -568.0% |
| Q3 25 | 8.7% | 15.2% | ||
| Q2 25 | — | 2.4% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | 7.0% | ||
| Q2 24 | 7.7% | 14.0% | ||
| Q1 24 | 0.7% | 5.1% | ||
| Q4 23 | — | 33.3% | ||
| Q3 23 | — | 12.0% |
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
